vs
摩托罗拉系统（ISSC）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是摩托罗拉系统的1.6倍（$35.5M vs $21.8M），摩托罗拉系统净利率更高（18.6% vs -304.2%，领先322.9%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 36.6%），摩托罗拉系统自由现金流更多（$7.0M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 42.5%）
摩托罗拉系统是一家美国科技企业，专注于研发供应安全防护相关产品与服务，总部位于伊利诺伊州芝加哥。公司主营关键通信、视频安防与指挥中心技术，相关产品与服务面向公共安全机构及各类企业。公司于2011年从原摩托罗拉拆分而来，是原摩托罗拉的合法继承主体，原摩托罗拉手机业务拆分后成为摩托罗拉移动。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
ISSC vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.6倍
$21.8M
营收增速更快
RXRX
高出645.2%
36.6%
净利率更高
ISSC
高出322.9%
-304.2%
自由现金流更多
ISSC
多$54.4M
$-47.3M
两年增速更快
RXRX
近两年复合增速
42.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.8M | $35.5M |
| 净利润 | $4.1M | $-108.1M |
| 毛利率 | 54.5% | 59.8% |
| 营业利润率 | 28.9% | -304.8% |
| 净利率 | 18.6% | -304.2% |
| 营收同比 | 36.6% | 681.7% |
| 净利润同比 | 451.4% | 39.6% |
| 每股收益（稀释后） | $0.22 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ISSCRXRX
| Q4 25 | $21.8M | $35.5M | ||
| Q3 25 | $22.2M | $5.2M | ||
| Q2 25 | $24.1M | $19.2M | ||
| Q1 25 | $21.9M | $14.7M | ||
| Q4 24 | $16.0M | $4.5M | ||
| Q3 24 | $15.4M | $26.1M | ||
| Q2 24 | $11.8M | $14.4M | ||
| Q1 24 | $10.7M | $13.8M |
净利润ISSCRXRX
| Q4 25 | $4.1M | $-108.1M | ||
| Q3 25 | $7.1M | $-162.3M | ||
| Q2 25 | $2.4M | $-171.9M | ||
| Q1 25 | $5.3M | $-202.5M | ||
| Q4 24 | $736.2K | $-178.9M | ||
| Q3 24 | $3.2M | $-95.8M | ||
| Q2 24 | $1.6M | $-97.5M | ||
| Q1 24 | $1.2M | $-91.4M |
毛利率ISSCRXRX
| Q4 25 | 54.5% | 59.8% | ||
| Q3 25 | 63.2% | -183.8% | ||
| Q2 25 | 35.5% | -4.9% | ||
| Q1 25 | 51.4% | -48.0% | ||
| Q4 24 | 41.4% | -181.4% | ||
| Q3 24 | 55.4% | 53.7% | ||
| Q2 24 | 53.4% | 36.2% | ||
| Q1 24 | 52.0% | 19.1% |
营业利润率ISSCRXRX
| Q4 25 | 28.9% | -304.8% | ||
| Q3 25 | 37.0% | -3327.6% | ||
| Q2 25 | 14.6% | -916.8% | ||
| Q1 25 | 31.8% | -1297.9% | ||
| Q4 24 | 8.4% | -4042.4% | ||
| Q3 24 | 28.4% | -377.1% | ||
| Q2 24 | 17.3% | -697.4% | ||
| Q1 24 | 15.3% | -698.4% |
净利率ISSCRXRX
| Q4 25 | 18.6% | -304.2% | ||
| Q3 25 | 32.0% | -3135.3% | ||
| Q2 25 | 10.1% | -894.2% | ||
| Q1 25 | 24.3% | -1373.3% | ||
| Q4 24 | 4.6% | -3935.5% | ||
| Q3 24 | 20.7% | -367.5% | ||
| Q2 24 | 13.2% | -676.6% | ||
| Q1 24 | 11.3% | -662.4% |
每股收益（稀释后）ISSCRXRX
| Q4 25 | $0.22 | $-0.17 | ||
| Q3 25 | $0.40 | $-0.36 | ||
| Q2 25 | $0.14 | $-0.41 | ||
| Q1 25 | $0.30 | $-0.50 | ||
| Q4 24 | $0.04 | $-0.56 | ||
| Q3 24 | $0.18 | $-0.34 | ||
| Q2 24 | $0.09 | $-0.40 | ||
| Q1 24 | $0.07 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.3M | $743.3M |
| 总债务越低越好 | $23.8M | $9.6M |
| 股东权益账面价值 | $68.7M | $1.1B |
| 总资产 | $109.9M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.35× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资ISSCRXRX
| Q4 25 | $8.3M | $743.3M | ||
| Q3 25 | $2.7M | $659.8M | ||
| Q2 25 | $601.8K | $525.1M | ||
| Q1 25 | $1.2M | $500.5M | ||
| Q4 24 | $604.6K | $594.4M | ||
| Q3 24 | $539.0K | $427.6M | ||
| Q2 24 | $521.0K | $474.3M | ||
| Q1 24 | $574.1K | $296.3M |
总债务ISSCRXRX
| Q4 25 | $23.8M | $9.6M | ||
| Q3 25 | $24.4M | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益ISSCRXRX
| Q4 25 | $68.7M | $1.1B | ||
| Q3 25 | $64.6M | $1.0B | ||
| Q2 25 | $56.8M | $919.1M | ||
| Q1 25 | $53.5M | $933.9M | ||
| Q4 24 | $47.8M | $1.0B | ||
| Q3 24 | $46.6M | $524.6M | ||
| Q2 24 | $43.2M | $584.4M | ||
| Q1 24 | $41.4M | $401.2M |
总资产ISSCRXRX
| Q4 25 | $109.9M | $1.5B | ||
| Q3 25 | $103.4M | $1.4B | ||
| Q2 25 | $91.8M | $1.3B | ||
| Q1 25 | $89.9M | $1.3B | ||
| Q4 24 | $81.3M | $1.4B | ||
| Q3 24 | $82.4M | $726.5M | ||
| Q2 24 | $59.8M | $775.9M | ||
| Q1 24 | $57.6M | $557.8M |
负债/权益比ISSCRXRX
| Q4 25 | 0.35× | 0.01× | ||
| Q3 25 | 0.38× | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.2M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $7.0M | $-47.3M |
| 自由现金流率自由现金流/营收 | 32.3% | -133.1% |
| 资本支出强度资本支出/营收 | 5.1% | 3.5% |
| 现金转化率经营现金流/净利润 | 2.01× | — |
| 过去12个月自由现金流最近4个季度 | $12.3M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流ISSCRXRX
| Q4 25 | $8.2M | $-46.1M | ||
| Q3 25 | $3.0M | $-117.4M | ||
| Q2 25 | $7.2M | $-76.4M | ||
| Q1 25 | $1.3M | $-132.0M | ||
| Q4 24 | $1.8M | $-115.4M | ||
| Q3 24 | $445.3K | $-59.2M | ||
| Q2 24 | $934.1K | $-82.2M | ||
| Q1 24 | $201.1K | $-102.3M |
自由现金流ISSCRXRX
| Q4 25 | $7.0M | $-47.3M | ||
| Q3 25 | $2.0M | $-117.6M | ||
| Q2 25 | $3.5M | $-79.6M | ||
| Q1 25 | $-267.7K | $-133.8M | ||
| Q4 24 | $1.6M | $-116.7M | ||
| Q3 24 | $299.5K | $-63.8M | ||
| Q2 24 | $730.8K | $-83.4M | ||
| Q1 24 | $75.4K | $-109.0M |
自由现金流率ISSCRXRX
| Q4 25 | 32.3% | -133.1% | ||
| Q3 25 | 8.8% | -2272.5% | ||
| Q2 25 | 14.6% | -413.9% | ||
| Q1 25 | -1.2% | -907.4% | ||
| Q4 24 | 9.9% | -2567.7% | ||
| Q3 24 | 1.9% | -244.6% | ||
| Q2 24 | 6.2% | -578.5% | ||
| Q1 24 | 0.7% | -789.9% |
资本支出强度ISSCRXRX
| Q4 25 | 5.1% | 3.5% | ||
| Q3 25 | 4.5% | 4.7% | ||
| Q2 25 | 15.3% | 16.4% | ||
| Q1 25 | 7.1% | 12.4% | ||
| Q4 24 | 1.6% | 28.6% | ||
| Q3 24 | 0.9% | 17.5% | ||
| Q2 24 | 1.7% | 8.2% | ||
| Q1 24 | 1.2% | 48.2% |
现金转化率ISSCRXRX
| Q4 25 | 2.01× | — | ||
| Q3 25 | 0.42× | — | ||
| Q2 25 | 2.95× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 2.50× | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.60× | — | ||
| Q1 24 | 0.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ISSC
| Products | $13.6M | 62% |
| Services | $8.2M | 38% |
RXRX
暂无分部数据
